Inhibition of the Nrf2-TrxR Axis Sensitizes the Drug-Resistant Chronic Myelogenous Leukemia Cell Line K562/G01 to Imatinib Treatments

doi 10.26434/chemrxiv.9755543.v1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Chemical Society (ACS)